Torquil Jackson

Torquil Jackson is an experienced professional in the field of investment and business development within the life sciences sector. Currently serving as an Investment Manager at Cancer Research Horizons since January 2020, Torquil has also held positions including Investment Analyst, Business Development Manager, and Business Development Associate at the same organization. In addition, Torquil is a Board Observer at Verinnogen and previously worked as a Technology Transfer and Partnerships Officer at MRC Harwell Institute. Torquil completed a PhD focusing on the effects of Duchenne Muscular Dystrophy-like pathology on the brain's cerebellum at the University of Portsmouth, where Torquil also earned a Bachelor of Science in Pharmacology. Early career experience includes a role as a Quality Assurance Administrator at Mitsubishi Tanabe Pharma Europe Ltd.